A member of the billionaire family that owns Purdue Pharmaceuticals, which is currently the target of multiple lawsuits over its complicity in perpetuating the opioid crisis, just received rights to a patent for a drug intended to curb the opioid crisis.
Dr. Richard Sackler is listed as one of six inventors of the patent, which was approved in January but came to light this week in a report from the Financial Times. The patent office granted the rights to Rhodes Pharmaceuticals, a subsidiary of Purdue.
The patent is for a new version of the drug buprenorphine, which is already FDA approved in tablet and film form. The new version would come in wafer form, meaning it can dissolve more quickly. According to claims in the patent, the faster the treatment dissolves, the less risk of diversion among addicts.
The patent was granted amid lawsuits from 1,000 jurisdictions against Purdue Pharmaceuticals, which has been accused of marketing Oxycontin, a popular opioid, despite knowing the great risks of addiction the drug carried. Another suit targets the Sackler family directly.
More
DelMarVa's Premier Source for News, Opinion, Analysis, and Human Interest Contact Publisher Joe Albero at alberobutzo@wmconnect.com or 410-430-5349
Must be a Democrat: manifesting a problem in order to create a solution that never would have happened.
ReplyDeleteIt's like giving you a disease and then selling you a cure.
ReplyDeleteThats what the FDA does. Poisions our food so they give us cancer then approve drugs that cure nothing but create allot of drug addicts.
ReplyDeleteIt's like robbing your house and then turn around and sell you a security system. Been known to happen.
ReplyDelete